Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
1.395
+0.135 (10.71%)
Oct 31, 2025, 10:27 AM EDT - Market open

Tenaya Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
227113221129782-
Upgrade
Market Cap Growth
70.53%-48.67%71.58%-83.56%--
Upgrade
Enterprise Value
14648105-5518-
Upgrade
Last Close Price
1.261.433.242.0118.95-
Upgrade
PB Ratio
2.061.221.580.532.81-
Upgrade
P/TBV Ratio
2.061.221.580.532.81-
Upgrade
Debt / Equity Ratio
0.120.150.090.060.06-
Upgrade
Quick Ratio
5.663.854.607.7911.5425.50
Upgrade
Current Ratio
6.004.224.917.9911.7325.78
Upgrade
Return on Equity (ROE)
-85.21%-95.69%-64.83%-47.39%-34.80%-45.51%
Upgrade
Return on Assets (ROA)
-45.12%-49.90%-36.49%-26.47%-19.68%-26.13%
Upgrade
Return on Capital (ROIC)
-49.21%-56.11%-39.97%-28.41%-20.99%-28.82%
Upgrade
Earnings Yield
-48.51%-98.10%-56.23%-96.15%-9.30%-
Upgrade
FCF Yield
-37.92%-80.79%-46.81%-97.23%-10.98%-
Upgrade
Buyback Yield / Dilution
-41.30%-14.96%-64.61%-152.75%-1724.33%-28.62%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q